Cite

    Ishida, J. et al. (2015). Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?. Journal of cachexia, sarcopenia and muscle. 6 (4), pp. 391-392. [Online].